Health and Healthcare

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

76 Articles

Chris Lange | Sep 20, 2017 at 1:30 PM EDT

Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock

Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage…

Jon C. Ogg | Jun 27, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess…

Chris Lange | Jun 22, 2017 at 9:30 AM EDT

Jefferies Sees 6 Biotechs as Undervalued With Massive Upside

Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.

Jon C. Ogg | Jun 2, 2017 at 9:19 AM EDT

Top Analyst Upgrades and Downgrades: Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty, Yum China and Many More

The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian,…

Jon C. Ogg | May 16, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods,…

Jon C. Ogg | Apr 17, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

The top analyst upgrades, downgrades and initiations seen from Monday include Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald's and…

Jon C. Ogg | Mar 30, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.

Chris Lange | Jan 24, 2017 at 12:15 PM EST

4 Speculative Biotech and Biohealth Analyst Upgrades

It seems that analysts are taking the forefront and making calls on where the biopharma industry is going ahead of…

Lee Jackson | Dec 12, 2016 at 8:20 AM EST

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political…

Lee Jackson | Oct 23, 2016 at 10:20 AM EDT

Famous Investor Continues Large Insider Buying: Lands’ End, Cree, Alnylam Pharmaceuticals, Cheniere Energy and More

Here are some of the companies that reported notable insider buying last week, including Cheniere Energy and Lands' End.

Lee Jackson | Oct 12, 2016 at 9:55 AM EDT

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good…

Chris Lange | Oct 8, 2016 at 9:55 AM EDT

5 Companies That Destroyed Shareholders This Past Week

The late-summer doldrums are over and the markets are on the move again as we are now in the fourth…

Jon C. Ogg | Oct 7, 2016 at 8:20 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Cliffs, Gap, KLA-Tencor, Regions Financial, Tyson Foods, Wal-Mart and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Advanced Micro Devices, Cliffs Natural Resources, Gap, KLA-Tencor,…

Paul Ausick | Oct 6, 2016 at 4:04 PM EDT

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

October 6, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in…

Chris Lange | Oct 6, 2016 at 11:35 AM EDT

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

Alnylam Pharmaceuticals saw its shares crash on Thursday after the company announced that it will be discontinuing one of its…

1 2 3 4 5 6

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

Jefferies Sees 6 Biotechs as Undervalued With Massive Upside

Top Analyst Upgrades and Downgrades: Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty, Yum China and Many More

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

4 Speculative Biotech and Biohealth Analyst Upgrades

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Famous Investor Continues Large Insider Buying: Lands’ End, Cree, Alnylam Pharmaceuticals, Cheniere Energy and More

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

5 Companies That Destroyed Shareholders This Past Week

Top Analyst Upgrades and Downgrades: AMD, Cliffs, Gap, KLA-Tencor, Regions Financial, Tyson Foods, Wal-Mart and More

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

Jefferies Sees 6 Biotechs as Undervalued With Massive Upside

Top Analyst Upgrades and Downgrades: Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty, Yum China and Many More

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

4 Speculative Biotech and Biohealth Analyst Upgrades

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Famous Investor Continues Large Insider Buying: Lands’ End, Cree, Alnylam Pharmaceuticals, Cheniere Energy and More

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

5 Companies That Destroyed Shareholders This Past Week

Top Analyst Upgrades and Downgrades: AMD, Cliffs, Gap, KLA-Tencor, Regions Financial, Tyson Foods, Wal-Mart and More

Alnylam, Mylan Tumble into Thursday’s 52-Week Low Club

Alnylam Pharma Crashes on Discontinued Late-Stage Trial

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s